Benzinga | Apr 23, 2021 08:00AM EDT

Raymond James Reiterates Outperform on HCA Healthcare, Raises Price Target to $225

Raymond James analyst John Ransom reiterates HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $190 to $225.